Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:11:33 EDT Thu 03 Jul 2025
Enter Symbol
or Name
USA
CA



T:CWEB - CHARLOTTE'S WEB HOLDINGS, INC. - https://www.charlottesweb.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CWEB - T  6.50.12·0.135.50.12-0.005-4.013.01120.125  0.13  0.120.27  0.07515:59:59Jun 1315 min RT 2¢
TSX - T6.50.12·0.135.50.1254.6130.125  0.125  0.1250.27  0.07511:06:0315 min
Alpha - A 0.13+0.0054.06.5130.13  0.13  0.1312:25:0715 min
CX2 - H 0.12-0.005-4.01.530.13  0.13  0.1215:59:5915 min
CXD - D 0.1250.32    Jun 0615 min
TriAct - M 0.1250.11    Sep 10-2015 min

Recent Trades - Last 10 of 12
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59H0.12-0.0055001 Anonymous79 CIBCK
14:43:11H0.130.0055009 BMO Nesbitt2 RBCK
14:43:11H0.130.0055009 BMO Nesbitt1 AnonymousK
13:11:14M0.12-0.00510080 National Bank80 National BankE
12:25:07A0.130.00550014 Virtu ITG1 AnonymousK
12:25:06A0.130.0051,00014 Virtu ITG1 AnonymousK
12:25:05A0.130.0055,00014 Virtu ITG1 AnonymousK
11:06:03D0.125 3001 Anonymous39 Merrill LynchE
11:06:03T0.125 2,50089 Raymond James39 Merrill LynchK
11:03:25T0.125 2,00089 Raymond James80 National BankKL

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-13 17:20C:CWEB0.125News ReleaseCharlotte's Web shareholders elect six directors at AGM
2025-05-27 08:07C:CWEB0.13News ReleaseCharlotte's Web(TM) Unveiling Brightside(TM) Precision-Formulated Approach to Hemp-Derived THC at Benzinga Conference
2025-05-14 07:15C:CWEB0.125SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-14 07:15C:CWEB0.125SEDAR Interim MD & ASEDAR Interim MD & A
2025-05-14 07:07C:CWEB0.125News ReleaseCharlotte's Web Reports Year-Over-Year Growth For Q1 2025
2025-03-19 07:27C:CWEB0.13SEDAR MD & ASEDAR MD & A
2025-03-19 07:22C:CWEB0.13SEDAR Annual ReportSEDAR Annual Report
2025-03-19 07:16C:CWEB0.13SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-03-19 07:07C:CWEB0.13News ReleaseCharlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results
2025-02-25 17:44C:CWEB0.145News ReleaseCharlotte's Web to release 2024 results March 19
2025-02-24 17:38C:CWEB0.155News ReleaseCharlotte's Web's DeFloria to enter phase 2 trial
2025-02-24 07:33C:CWEB0.14News ReleaseDeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)
2024-12-12 17:19C:CWEB0.16News ReleaseCharlotte's JV DeFloria releases AJA001 phase 1 results
2024-12-12 09:12C:CWEB0.148News ReleaseCharlotte's Web Provides Update on DeFloria's Phase 1 Results Targeting Autism Spectrum Disorder
2024-11-14 07:33C:CWEB0.20SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-14 07:32C:CWEB0.20SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-14 07:07C:CWEB0.20News ReleaseCharlotte's Web Reports 2024 Third quarter Financial Results
2024-10-07 13:21C:CWEB0.18News ReleaseTilray Brands rolls out Charlotte's Web gummies in Ont.
2024-10-01 11:52C:CWEB0.195News ReleaseONE HEMP Hails Long Overdue Congressional Action Toward the Regulation of CBD as a Dietary Supplement
2024-09-24 15:09C:CWEB0.19News ReleaseCharlotte's Web opposes Calif. regulations on hemp sale